| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.64▲ | 5.64▲ | 5.63▲ | 5.63▲ | 5.69▼ |
| MA10 | 5.64▲ | 5.64▲ | 5.62▲ | 5.62▲ | 5.41▲ |
| MA20 | 5.63▲ | 5.62▲ | 5.63▲ | 5.65▼ | 5.93▼ |
| MA50 | 5.63▲ | 5.72▼ | 5.69▼ | 5.49▲ | 6.27▼ |
| MA100 | 5.62▲ | 5.68▼ | 5.72▼ | 6.05▼ | 6.60▼ |
| MA200 | 5.64▲ | 5.72▼ | 5.55▲ | 6.36▼ | 7.15▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.006▲ | 0.001▲ | -0.012▼ | 0.017▲ |
| RSI | 60.245▲ | 50.486▲ | 49.109▼ | 52.289▲ | 45.803▼ |
| STOCH | 84.167▲ | 47.551 | 48.961 | 28.164 | 51.009 |
| WILL %R | 0.000▲ | -36.585 | -57.377 | -70.330 | -48.571 |
| CCI | 140.230▲ | 39.036 | 2.162 | -36.116 | 15.400 |
|
Thursday, April 30, 2026 11:09 PM
Investors liked what they saw with the company's opening 2026 earnings report.
|
|
Thursday, April 30, 2026 01:36 AM
Bausch Health Companies Inc (BHC) reports a robust 14% revenue increase, driven by Salix and Solta, while navigating challenges in its diversified segment.
|
|
Wednesday, April 29, 2026 08:02 PM
Q1 2026 earnings call recap: revenue/EBITDA beat, 2026 guidance reaffirmed, Xifaxan & Solta China surge, tariffs/IRA risks—read now.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/05/26 | 5.58 | 5.725 | 5.57 | 5.65 | 28,455 |
| 04/05/26 | 5.65 | 5.8273 | 5.52 | 5.53 | 2,370,391 |
| 01/05/26 | 5.72 | 5.72 | 5.38 | 5.65 | 3,080,358 |
| 30/04/26 | 5.85 | 6.29 | 5.71 | 5.72 | 6,279,774 |
| 29/04/26 | 5.59 | 5.66 | 5.465 | 5.59 | 1,440,033 |
| 28/04/26 | 5.62 | 5.785 | 5.60 | 5.67 | 2,531,570 |
| 27/04/26 | 5.62 | 5.78 | 5.57 | 5.58 | 1,366,283 |
| 24/04/26 | 5.62 | 5.63 | 5.49 | 5.63 | 1,237,309 |
| 23/04/26 | 5.69 | 5.72 | 5.505 | 5.54 | 1,336,293 |
| 22/04/26 | 5.78 | 5.79 | 5.565 | 5.68 | 764,659 |
|
|
||||
|
|
||||
|
|